Aspen Pharmacare APNHF Stock
Aspen Pharmacare Price Chart
Aspen Pharmacare APNHF Financial and Trading Overview
| Aspen Pharmacare stock price | 8.7 USD |
| Previous Close | 8.7 USD |
| Open | 8.2 USD |
| Bid | 8.36 USD x 10000 |
| Ask | 9.35 USD x 20000 |
| Day's Range | 8.2 - 8.2 USD |
| 52 Week Range | 6.23 - 12.25 USD |
| Volume | 6.1K USD |
| Avg. Volume | 198 USD |
| Market Cap | 3.64B USD |
| Beta (5Y Monthly) | 0.341 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.25 USD |
| Forward Dividend & Yield | 0.12 (1.39%) |
| Ex-Dividend Date | October 1, 2025 |
| 1y Target Est | N/A |
APNHF Valuation Measures
| Enterprise Value | 31.19B USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.085485175 |
| Price/Book (mrq) | 0.73038936 |
| Enterprise Value/Revenue | 0.732 |
| Enterprise Value/EBITDA | 4.1 |
Trading Information
Aspen Pharmacare Stock Price History
| Beta (5Y Monthly) | 0.341 |
| 52-Week Change | -28.95% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 12.25 USD |
| 52 Week Low | 6.23 USD |
| 50-Day Moving Average | 8.54 USD |
| 200-Day Moving Average | 7.37 USD |
APNHF Share Statistics
| Avg. Volume (3 month) | 198 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 444.02M |
| Float | 366.58M |
| Short Ratio | N/A |
| % Held by Insiders | 7.66% |
| % Held by Institutions | 66.34% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.11 |
| Trailing Annual Dividend Yield | 24.25% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.35599998 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | June 30, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | June 30, 2026 |
Profitability
| Profit Margin | -4.69% |
| Operating Margin (ttm) | 10.65% |
| Gross Margin | 42.98% |
| EBITDA Margin | 17.86% |
Management Effectiveness
| Return on Assets (ttm) | 2.85% |
| Return on Equity (ttm) | -2.17% |
Income Statement
| Revenue (ttm) | 42.59B USD |
| Revenue Per Share (ttm) | 95.87 USD |
| Quarterly Revenue Growth (yoy) | -4.29% |
| Gross Profit (ttm) | 18.31B USD |
| EBITDA | 7.61B USD |
| Net Income Avi to Common (ttm) | -1806000000 USD |
| Diluted EPS (ttm) | -0.25 |
| Quarterly Earnings Growth (yoy) | -38.39% |
Balance Sheet
| Total Cash (mrq) | 5.62B USD |
| Total Cash Per Share (mrq) | 12.64 USD |
| Total Debt (mrq) | 32.94B USD |
| Total Debt/Equity (mrq) | 40.63 USD |
| Current Ratio (mrq) | 3.635 |
| Book Value Per Share (mrq) | 11.226889 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 6.93B USD |
| Levered Free Cash Flow (ttm) | -17675999232 USD |
Profile of Aspen Pharmacare
| Country | United States |
| State | N/A |
| City | Durban |
| Address | Aspen Place |
| ZIP | N/A |
| Phone | 27 31 580 8600 |
| Website | https://www.aspenpharma.com |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector(s) | Healthcare |
| Full Time Employees | 9128 |
Aspen Pharmacare Holdings Limited, together with its subsidiaries, manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia. It operates through Commercial Pharmaceuticals and Manufacturing segments. The company offers injectables for therapeutic areas, such as anaesthetics, anticoagulants, antithrombotic agents, analgesics, and hormone replacement medicines under the Arixtra, Diprivan, Fraxiparine, Marcaine, Sustanon, and Xylocaine brands; over-the-counter medicines under the Emla, Maltofer, Ovestin, Solpadeine, and Xylocaine brands; and prescription products for anti-inflammatories, immunosuppressants, hypothyroidism, anti-gout, analgesics, and corticosteroids under the Eltroxin, Imuran, Lipitor, Lyrica, and Zyloric brands. It also manufactures active pharmaceutical ingredients, finished dose forms, and heparins, as well as steriles, oral solid doses, liquids, semi-solids, and biologicals. The company exports its products. Aspen Pharmacare Holdings Limited was founded in 1850 and is headquartered in Durban, South Africa.
Q&A For Aspen Pharmacare Stock
What is a current APNHF stock price?
Aspen Pharmacare APNHF stock price today per share is 8.7 USD.
How to purchase Aspen Pharmacare stock?
You can buy APNHF shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Aspen Pharmacare?
The stock symbol or ticker of Aspen Pharmacare is APNHF.
Which industry does the Aspen Pharmacare company belong to?
The Aspen Pharmacare industry is Drug Manufacturers - Specialty & Generic.
How many shares does Aspen Pharmacare have in circulation?
The max supply of Aspen Pharmacare shares is 444.02M.
What is Aspen Pharmacare Price to Earnings Ratio (PE Ratio)?
Aspen Pharmacare PE Ratio is now.
What was Aspen Pharmacare earnings per share over the trailing 12 months (TTM)?
Aspen Pharmacare EPS is -0.25 USD over the trailing 12 months.
Which sector does the Aspen Pharmacare company belong to?
The Aspen Pharmacare sector is Healthcare.